NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 79 filers reported holding NOVOCURE LTD in Q4 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $14,837,000 | +33.8% | 308,007 | -7.0% | 0.01% | +22.2% |
| Q4 2018 | $11,091,000 | -68.6% | 331,271 | -50.9% | 0.01% | -25.0% |
| Q3 2018 | $35,328,000 | +195.8% | 674,202 | +76.7% | 0.01% | +50.0% |
| Q2 2018 | $11,943,000 | +71.4% | 381,577 | +19.4% | 0.01% | +60.0% |
| Q1 2018 | $6,968,000 | +149.7% | 319,613 | +131.4% | 0.01% | +150.0% |
| Q4 2017 | $2,790,000 | -7.6% | 138,136 | -9.2% | 0.00% | 0.0% |
| Q3 2017 | $3,019,000 | +12.4% | 152,102 | -2.1% | 0.00% | 0.0% |
| Q2 2017 | $2,687,000 | +139.5% | 155,333 | +12.1% | 0.00% | +100.0% |
| Q1 2017 | $1,122,000 | -0.6% | 138,573 | -3.7% | 0.00% | 0.0% |
| Q4 2016 | $1,129,000 | -14.1% | 143,878 | -6.5% | 0.00% | 0.0% |
| Q3 2016 | $1,315,000 | -26.4% | 153,952 | +0.5% | 0.00% | 0.0% |
| Q2 2016 | $1,787,000 | +325.5% | 153,127 | +428.2% | 0.00% | – |
| Q1 2016 | $420,000 | -35.2% | 28,991 | 0.0% | 0.00% | – |
| Q4 2015 | $648,000 | – | 28,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $29,071,000 | 12.94% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Deep Track Capital, LP | 1,000,000 | $82,850,000 | 5.31% |
| MORGAN JESS S & CO INC | 48,860 | $4,048,000 | 2.94% |
| Taylor Frigon Capital Management LLC | 73,014 | $6,049,000 | 2.24% |
| Private Harbour Investment Management & Counsel, LLC | 13,263 | $1,099,000 | 0.92% |
| HighVista Strategies LLC | 17,448 | $1,446,000 | 0.92% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $829,000 | 0.79% |
| Lloyd Park, LLC | 6,700 | $555,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 69,700 | $5,775,000 | 0.57% |